Market Overview

Chardan: R1 RCM Will Make A Full Recovery

Share:

Even as it reflects on 56-percent year-over-year gains, R1 RCM Inc (NASDAQ: RCM) has struck an “attractive inflection point,” according to Chardan Capital Markets.

The Rating

Analyst Steven Wardell initiated coverage on R1 RCM with a Buy rating and a $17 price target.

The Thesis

Chardan expects superior top-line growth in RCM relative to peers, particularly given the firm’s high recurring revenue rate and recent expansion beyond its core Ascension business.

“We like the company’s ability to boost hospital economics in ways that are strong compared to revenue cycle competitors,” Wardell wrote in a Tuesday note.

He regards RCM as a leading revenue-cycle-management vendor in the U.S. hospital market and expects continued growth as macro trends favor increased software and service outsourcing. Chardan’s channel checks indicate a shift in hospital budgets toward revenue-cycle-management services previously done in-house.

In these circumstances, Wardell sees a $100 billion market with 12-percent growth.

“The Street sees R1 RCM as a fallen angel in the middle of a turnaround,” Wardell wrote. “We look positively on the turnaround and see the opportunity for multiple expansion in the stock in the next 12 months.”

Price Action

At time of publication, R1 RCM shares were up 4.5 percent at $10.43.

Related Links:

LifePoint Confirms Sale To Apollo's RCCH, But Analysts Aren't Too Enthusiastic

Morgan Stanley: Veeva Systems' Share Price Fails To Reflect Growth, Margin Potential

Latest Ratings for RCM

DateFirmActionFromTo
Jan 2020KeyBancMaintainsOverweight
Jan 2019KeyBancInitiates Coverage OnOverweight
Dec 2018CitigroupInitiates Coverage OnBuy

View More Analyst Ratings for RCM
View the Latest Analyst Ratings

 

Related Articles (RCM)

View Comments and Join the Discussion!

Posted-In: Chardan Capital Markets Steven WardellAnalyst Color Price Target Initiation Analyst Ratings

Latest Ratings

StockFirmActionPT
ONNeedhamMaintains17.0
MCHPNeedhamMaintains96.0
MOHB of A SecuritiesUpgrades
NBRVNeedhamDowngrades
SAGECanaccord GenuityMaintains80.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com